These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22525856)

  • 1. Central retroperitoneal recurrences from colorectal cancer: are lymph node and locoregional recurrences the same disease?
    Dumont F; Kothodinis K; Goéré D; Honoré C; Dartigues P; Boige V; Ducreux M; Malka D; Elias D
    Eur J Surg Oncol; 2012 Jul; 38(7):611-6. PubMed ID: 22525856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients.
    van Dalen T; Hoekstra HJ; van Geel AN; van Coevorden F; Albus-Lutter C; Slootweg PJ; Hennipman A;
    Eur J Surg Oncol; 2001 Sep; 27(6):564-8. PubMed ID: 11520090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymph node ratio in stage III colorectal cancer.
    Wong KP; Poon JT; Fan JK; Law WL
    Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The primary tumour resection with extended D3 lymph node dissection, metastases of synchronous metastatic colorectal cancer].
    Tsar'kov PV; Kravchenko AIu; Tulina IA; Mirakian SS
    Khirurgiia (Mosk); 2012; (6):28-35. PubMed ID: 22951611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery and intraoperative electron radiotherapy in recurrent or metastatic oligotopic extrapelvic cancer: long-term outcome.
    Calvo FA; González ME; González-San Segundo C; González-Bayón L; Lozano MA; Santos-Miranda JA; Alvarez E; García-Sabrido JL
    Eur J Surg Oncol; 2012 Oct; 38(10):955-61. PubMed ID: 22819147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma.
    Min BS; Kim NK; Sohn SK; Cho CH; Lee KY; Baik SH
    J Surg Oncol; 2008 Feb; 97(2):136-40. PubMed ID: 17963247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
    Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
    J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic lymph node size and colorectal cancer prognosis.
    Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
    J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and risk factors for colorectal cancer recurrence.
    Dogan L; Karaman N; Yilmaz KB; Ozaslan C; Atalay C; Altinok M
    J BUON; 2010; 15(1):61-7. PubMed ID: 20414929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal ratios in node-positive breast cancer--long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy.
    Tai P; Joseph K; Sadikov E; Mahmood S; Lien F; Yu E
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):662-6. PubMed ID: 17449196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
    Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
    Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of radiotherapy in the multidisciplinary treatment of isolated retroperitoneal lymph node recurrence from colorectal cancer.
    Lee J; Chang JS; Shin SJ; Lim JS; Keum KC; Kim NK; Ahn JB; Kim TI; Koom WS
    Ann Surg Oncol; 2015 May; 22(5):1520-6. PubMed ID: 25589152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.